How lending to payers could get your drug to market
This article was originally published in Scrip
Executive Summary
Debt financing agreements, often coupled with performance guarantees and added services, could be the way to convince budget-conscious payers to pay out for your expensive drug, according to Soeren Mattke, senior scientist at the Rand Corporation, a research organization that develops public policy solutions.